Filing Details
- Accession Number:
- 0001181431-12-049907
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-11 17:40:35
- Reporting Period:
- 2012-09-07
- Filing Date:
- 2012-09-11
- Accepted Time:
- 2012-09-11 17:40:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1113148 | Infinity Pharmaceuticals Inc. | INFI | Pharmaceutical Preparations (2834) | 330655706 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1450997 | Rosebay Medical Co L.p. | C/O North Bay Associates 14000 Quail Springs Parkway #2200 Oklahoma City OK 73134 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-09-07 | 5,416,565 | $14.50 | 5,416,565 | No | 4 | P | Indirect | By Purdue Pharma L.P. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Purdue Pharma L.P. |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Purchase Warrants (right to buy) | Acquisiton | 2009-01-07 | 500,000 | $0.00 | 500,000 | $20.00 |
| Common Stock | Stock Purchase Warrants (right to buy) | Acquisiton | 2009-01-07 | 1,000,000 | $0.00 | 1,000,000 | $30.00 |
| Common Stock | Stock Purchase Warrants (right to buy) | Acquisiton | 2009-01-07 | 1,500,000 | $0.00 | 1,500,000 | $40.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-01-07 | 2010-07-01 | No | 4 | H | Direct |
| 0 | 2009-01-07 | 2011-07-01 | No | 4 | H | Direct |
| 0 | 2009-01-07 | 2012-07-02 | No | 4 | H | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 3,000,000 | Direct |
Footnotes
- These securities were purchased by Purdue Pharma L.P. pursuant to the Securities Purchase Agreement between the Issuer, Purdue Pharma L.P., Beacon Company and the Reporting Person, dated July 17, 2012 (the "Securities Purchase Agreement"). The Reporting Person and Beacon Company are the ultimate parents of Purdue Pharma L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.
- These warrants expired and were not exercised by the holder.
Billionaire Hedge Funds
